Qube Research & Technologies LTD Biomarin Pharmaceutical Inc Transaction History
Qube Research & Technologies LTD
- $91.4 Billion
- Q3 2025
A detailed history of Qube Research & Technologies LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 260,229 shares of BMRN stock, worth $14.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
260,229
Previous 640,393
59.36%
Holding current value
$14.2 Million
Previous $35.2 Million
59.96%
% of portfolio
0.02%
Previous 0.04%
Shares
25 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
182MCall Options Held
1.52MPut Options Held
1.01M-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$833 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$804 Million0.46% of portfolio
-
State Street Corp Boston, MA8.76MShares$480 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...